ICU Medical Gross Margin 2010-2023 | ICUI
Current and historical gross margin for ICU Medical (ICUI) over the last 10 years. The current gross profit margin for ICU Medical as of December 31, 2023 is %.
| ICU Medical Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $2.26B | $0.74B | 32.76% |
| 2023-09-30 | $2.25B | $0.74B | 33.04% |
| 2023-06-30 | $2.29B | $0.75B | 32.48% |
| 2023-03-31 | $2.31B | $0.72B | 31.27% |
| 2022-12-31 | $2.28B | $0.70B | 30.61% |
| 2022-09-30 | $2.04B | $0.65B | 31.82% |
| 2022-06-30 | $1.78B | $0.59B | 33.24% |
| 2022-03-31 | $1.54B | $0.55B | 35.54% |
| 2021-12-31 | $1.32B | $0.49B | 37.36% |
| 2021-09-30 | $1.30B | $0.49B | 37.42% |
| 2021-06-30 | $1.28B | $0.47B | 36.83% |
| 2021-03-31 | $1.26B | $0.45B | 35.95% |
| 2020-12-31 | $1.27B | $0.46B | 36.27% |
| 2020-09-30 | $1.27B | $0.46B | 35.91% |
| 2020-06-30 | $1.26B | $0.46B | 36.65% |
| 2020-03-31 | $1.26B | $0.46B | 36.23% |
| 2019-12-31 | $1.27B | $0.47B | 37.28% |
| 2019-09-30 | $1.29B | $0.49B | 38.22% |
| 2019-06-30 | $1.31B | $0.51B | 38.85% |
| 2019-03-31 | $1.36B | $0.56B | 41.02% |
| 2018-12-31 | $1.40B | $0.57B | 40.81% |
| 2018-09-30 | $1.43B | $0.57B | 40.10% |
| 2018-06-30 | $1.45B | $0.55B | 38.06% |
| 2018-03-31 | $1.42B | $0.49B | 34.30% |
| 2017-12-31 | $1.29B | $0.43B | 32.95% |
| 2017-09-30 | $1.02B | $0.34B | 33.37% |
| 2017-06-30 | $0.77B | $0.28B | 36.09% |
| 2017-03-31 | $0.54B | $0.24B | 44.80% |
| 2016-12-31 | $0.38B | $0.20B | 52.89% |
| 2016-09-30 | $0.37B | $0.20B | 52.94% |
| 2016-06-30 | $0.36B | $0.19B | 53.17% |
| 2016-03-31 | $0.35B | $0.19B | 53.43% |
| 2015-12-31 | $0.34B | $0.18B | 53.08% |
| 2015-09-30 | $0.33B | $0.17B | 52.27% |
| 2015-06-30 | $0.32B | $0.17B | 51.24% |
| 2015-03-31 | $0.32B | $0.16B | 50.16% |
| 2014-12-31 | $0.31B | $0.15B | 49.19% |
| 2014-09-30 | $0.31B | $0.15B | 49.19% |
| 2014-06-30 | $0.31B | $0.15B | 49.20% |
| 2014-03-31 | $0.31B | $0.15B | 49.20% |
| 2013-12-31 | $0.31B | $0.16B | 49.36% |
| 2013-09-30 | $0.32B | $0.16B | 49.53% |
| 2013-06-30 | $0.32B | $0.16B | 49.84% |
| 2013-03-31 | $0.32B | $0.16B | 50.48% |
| 2012-12-31 | $0.32B | $0.16B | 49.53% |
| 2012-09-30 | $0.31B | $0.15B | 48.71% |
| 2012-06-30 | $0.31B | $0.15B | 47.87% |
| 2012-03-31 | $0.31B | $0.14B | 46.73% |
| 2011-12-31 | $0.30B | $0.14B | 47.51% |
| 2011-09-30 | $0.30B | $0.14B | 47.83% |
| 2011-06-30 | $0.30B | $0.14B | 47.16% |
| 2011-03-31 | $0.29B | $0.14B | 47.24% |
| 2010-12-31 | $0.28B | $0.13B | 45.58% |
| 2010-09-30 | $0.28B | $0.12B | 44.20% |
| 2010-06-30 | $0.25B | $0.11B | 44.49% |
| 2010-03-31 | $0.24B | $0.11B | 44.96% |
| 2009-12-31 | $0.23B | $0.11B | 46.93% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.333B | $2.259B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $186.151B | 24.44 |
| Stryker (SYK) | United States | $123.816B | 30.70 |
| Medtronic (MDT) | Ireland | $105.535B | 14.94 |
| Boston Scientific (BSX) | United States | $98.780B | 32.84 |
| EssilorLuxottica (ESLOY) | France | $98.612B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.070B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.534B | 29.36 |
| ResMed (RMD) | United States | $26.307B | 26.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.538B | 15.80 |
| Terumo (TRUMY) | Japan | $24.492B | 34.59 |
| Baxter (BAX) | United States | $20.044B | 14.62 |
| Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
| Insulet (PODD) | United States | $11.641B | 61.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.422B | 0.00 |
| Demant (WILYY) | Denmark | $9.965B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.977B | 23.77 |
| BellRing Brands (BRBR) | United States | $7.070B | 38.01 |
| Lantheus Holdings (LNTH) | United States | $4.374B | 11.29 |
| Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
| Haemonetics (HAE) | United States | $4.126B | 21.10 |
| GN Store Nord (GNNDY) | Denmark | $3.707B | 24.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.459B | 16.35 |
| Envista Holdings (NVST) | United States | $3.430B | 13.05 |
| QuidelOrtho (QDEL) | United States | $2.616B | 9.50 |
| Green Thumb Industries (GTBIF) | United States | $2.602B | 82.47 |
| Neogen (NEOG) | United States | $2.515B | 24.19 |
| TG Therapeutics (TGTX) | United States | $2.130B | 689.00 |
| Owens & Minor (OMI) | United States | $1.899B | 18.23 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.835B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.710B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.659B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.471B | 45.81 |
| InMode (INMD) | Israel | $1.462B | 7.57 |
| LeMaitre Vascular (LMAT) | United States | $1.420B | 46.86 |
| AdaptHealth (AHCO) | United States | $1.241B | 9.34 |
| Warby Parker (WRBY) | United States | $1.185B | 0.00 |
| AtriCure (ATRC) | United States | $1.122B | 0.00 |
| MacroGenics (MGNX) | United States | $0.977B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.723B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.690B | 14.90 |
| Evolus (EOLS) | United States | $0.668B | 0.00 |
| Quanterix (QTRX) | United States | $0.605B | 0.00 |
| Jin Medical (ZJYL) | China | $0.600B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.539B | 11.67 |
| Valneva SE (VALN) | France | $0.528B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.481B | 0.00 |
| PetIQ (PETQ) | United States | $0.479B | 17.89 |
| ZimVie (ZIMV) | United States | $0.420B | 25.72 |
| Biote (BTMD) | United States | $0.413B | 3.93 |
| OraSure Technologies (OSUR) | United States | $0.404B | 6.68 |
| Surmodics (SRDX) | United States | $0.377B | 40.75 |
| Zynex (ZYXI) | United States | $0.366B | 42.15 |
| Aurora Cannabis (ACB) | Canada | $0.352B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.305B | 30.31 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.246B | 15.01 |
| Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
| Veru (VERU) | United States | $0.192B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.180B | 0.00 |
| High Tide (HITI) | Canada | $0.179B | 0.00 |
| Omeros (OMER) | United States | $0.177B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 21.39 |
| Eagleford Energy (GRUSF) | United States | $0.126B | 63.55 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| InterCure (INCR) | Israel | $0.115B | 19.46 |
| Fonar (FONR) | United States | $0.106B | 9.14 |
| MariMed (MRMD) | United States | $0.101B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Safety Shot (SHOT) | United States | $0.091B | 0.00 |
| Brainsway (BWAY) | Israel | $0.081B | 0.00 |
| Chimerix (CMRX) | United States | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.071B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| United Health Products (UEEC) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.30 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.64 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |